CNS Summit

RSSTrial Methodology

Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?

Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?

| January 1, 2020

Continue Reading

The Effect of Acutely Administered Propofol on Forced Swim Test Outcomes in Mice

The Effect of Acutely Administered Propofol on Forced Swim Test Outcomes in Mice

| September 1, 2019

Continue Reading

Correlation Between the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale and Nonmotor Scales in Patients with Parkinson’s Disease

Correlation Between the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale and Nonmotor Scales in Patients with Parkinson’s Disease

| September 1, 2019

Continue Reading

CNS Summit 2019 Abstracts of Poster Presentations

CNS Summit 2019 Abstracts of Poster Presentations

| September 1, 2019

A message from the editor: Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with this reference guide to some of the innovative research that is being presented during CNS Summit 2019. The supplement is also available online by visiting […]

Continue Reading

Is High Placebo Response Really a Problem in Depression Trials? A Critical Re-analysis of Depression Studies

Is High Placebo Response Really a Problem in Depression Trials? A Critical Re-analysis of Depression Studies

| July 1, 2019

Continue Reading

Letter to the Editor: The Click-through Rate as a Measure of Dementia Health Promotion on YouTube

Letter to the Editor: The Click-through Rate as a Measure of Dementia Health Promotion on YouTube

| July 1, 2019

Continue Reading

Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study

Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study

| May 1, 2019

Continue Reading

Adult Neurogenesis in Humans: A Review of Basic Concepts, History, Current Research, and Clinical Implications

Adult Neurogenesis in Humans: A Review of Basic Concepts, History, Current Research, and Clinical Implications

| May 1, 2019

Continue Reading

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis

| March 1, 2019

Continue Reading

CNS Summit 2018 Abstracts of Poster Presentations

CNS Summit 2018 Abstracts of Poster Presentations

| November 1, 2018

Continue Reading

Next Page »